drugset / Trial / NCT01450189

A Key Link for Transmission Prevention

NCT01450189

RandomizedParallel-groupOpen-labelPrevention

Summary

This pilot study will assess the feasibility for the potential public health benefit of behavioral and antiretroviral interventions during acute HIV infection. Central Hypothesis The investigators hypothesize that delivering behavioral and antiretroviral interventions to acutely infected persons will reduce onward transmission.

Timeline

Start
2011-10
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Raltegravir Other / unclassified 400 mg Oral
Comparator Tenofovir disoproxil fumarate Small molecule 300 mg Oral
Comparator emtricitabine Other / unclassified 200 mg Oral